HSBC recently raised its target price for Intel from $100 to $200 per share.

This is one of the most aggressive target prices on Wall Street right now. I think we should be more patient going forward, looking toward the end of this year and next year, instead of obsessing over daily stock price fluctuations.
Several recent institutional reports have focused on the same thing: Intel Foundry's progress has accelerated significantly. The yield issues for 18A have been largely resolved, 18A-P has begun risk production, and 14A R&D continues to advance. As TSMC's advanced process nodes and CoWoS capacity remain tight, more customers are considering second sources, which has also brought more attention to Intel's EMIB advanced packaging. According to publicly available information, Terafab (a joint project of SpaceX, Tesla, and xAI), Google, Apple, Amazon, and Microsoft all have varying degrees of collaboration or project progress with Intel Foundry, and NVIDIA is still evaluating Intel's advanced packaging solutions.
Additionally, Intel recently raised the official suggested retail price for its Core Ultra processors, which indirectly reflects the company's increased confidence in product competitiveness and demand. What is truly worth watching next is the earnings report, to see if management will disclose more updates on Foundry, 18A, 14A, and external customers.
According to previously disclosed information, Pelosi recently purchased Intel long-term call options (LEAP Calls) expiring in March 2027.
The key focus remains on the company's business execution over the coming quarters. I am optimistic about Intel's earnings reports in the next few quarters.